CLINICAL BACTERIOLOGY Dr .Mostafa M. Eraqi Ph.D. Microbiology and Immunology A 44-year-old male presented to the emergency room with complaints of chest pain and was found to have suffered a myocardial infarction. His past medical history was significant for hypertension, noninsulin-dependent diabetes, hypercholesterolemia, and a history of heavy smoking (two packs per day for 15 years). A cardiac catheterization on hospital day 3 showed three vessel coronary artery disease, and he underwent triple coronary artery bypass graft surgery on hospital day 5. On hospital day 7, he developed septic shock with acute renal and respiratory failure requiring intubation. At that time, he had a fever of 39.3C, his arterial blood gas revealed a pO2 of 89 mmHg on 100% O2, and he had a white blood cell count of 27000/mm3. Two blood cultures were obtained. A chest radiograph showed a left lower lobe infiltrate with pleural effusion. A chest tube was placed to drain the effusion. On hospital day 11, pus was noted to be seeping from his sternal wound. His wound was debrided and a rib biopsy was performed. Blood, drainage from his chest tube, tracheal aspirates, pus from his sternal wound, and a rib biopsy were cultured. The bacterium isolated from the clinical specimens was a gram-positive, catalase-positive, coagulasepositive coccus that was resistant to methicillin. QUESTION What is the causative agent, how does it enter the body and how does it spread a) within the body and b) b) from person to person? Causative agent The patient has an infection caused by methicillin (oxacillin)-resistant Staphylococcus aureus (MRSA). Bacteria in the genus Staphylococcus are gram positive cocci that grow in grape-like clusters and produce the enzyme catalase. The genus Staphylococcus comprises some 35 species, many of which are members of the endogenous microbiota of the skin and mucous membranes of the gastrointestinal and genitourinary tracts of humans. Interestingly, a number of these species have defined habitats on the human body. Three species account for most human disease, namely S. aureus, S. epidermidis, and S. saprophyticus. Of these, S. aureus is the most pathogenic. S. aureus has a typical gram-positive cell wall that features a thick peptidoglycan layer extensively cross-linked with pentaglycine bridges. The extensive cross-linking makes the cell very resistant to drying so that staphylococci can survive on fomites (inanimate objects) for long periods of time. The wall also contains covalently bound teichoic acid and lipoteichoic acid, which is anchored in the cytoplasmic membrane. There are a number of molecules that are exposed on the cell surface. These are either anchored in the cytoplasmic membrane and traverse the cell wall to the outside or they are anchored in the wall and extend from it. Among the important cell surface-exposed molecules of S. aureus are various microbial surface components that recognize adhesive matrix molecules (MSCRAMMs). These components recognize and bind various extracellular matrix proteins such as fibronectin, collagen, and fibrinogen (clumping factor), and the Fc region of mammalian IgG (protein A). In addition to wall-associated clumping factor that binds solid-phase fibrinogen, S. aureus secretes coagulase, which binds soluble fibrinogen. Coagulase binds prothrombin in a 1:1 molar ratio to form a complex termed staphylothrombin, which converts fibrinogen to fibrin. Because S. aureus is the only staphylococcal species that possesses coagulase and protein A their detection serves as a method to identify the bacterium (see Section 4). MSCRAMMs facilitate invasion of keratinocytes and endothelial cells by S. aureus. Once taken up by cells, the bacteria survive in vacuoles and free in the cytoplasm where some persist for several days. Bacterial invasion results in cytotoxicity and apoptotic cell death. Almost all S. aureus clinical isolates produce capsular polysaccharides, which have been divided into 11 serotypes. Serotype 1 and 2 staphylococci are heavily capsulated and produce mucoid colonies. The remaining serotypes produce ‘microcapsules’ and form nonmucoid colonies. Interestingly, most clinical isolates are microcapsule-producing serotypes 5 and 8. Almost all strains of S. aureus secrete a group of enzymes and cytotoxins that includes four hemolysins (alpha, beta, gamma, and delta), nucleases, proteases, lipases, hyaluronidase, and collagenase. Alpha-toxin is a poreforming toxin that acts on many types of human cells. It is dermonecrotic and neurotoxic. Betatoxin is a sphingomyelinase C whose role in pathogenesis remains unclear. Delta-toxin is able to damage the membrane of many human cells, possibly by inserting into the cytoplasmic membrane and disordering lipid chain dynamics, although there are suggestions that it may form pores. Two types of bicomponent toxin are made by S. aureus, gamma-toxin and Panton-Valentine leukocidin (PVL). While gammatoxin is produced by almost all strains of S. aureus, PVL is produced by only a few percent of strains. The toxins affect neutrophils and macrophages. PVL has pore-forming activity and has been associated with necrotic lesions involving the skin and with severe necrotizing pneumonia in community-acquired S. aureus infections. Also, S. aureus produces a staphylokinase, which is a potent activator of plasminogen, the precursor of the fibrinolytic protease plasmin. S. aureus produces several families of exotoxins that have superantigen activity. These include heat-stable enterotoxins (A– E, G–I) that cause food poisoning, exfoliative (epidermolytic) toxins A (chromosome encoded) and B (plasmid encoded) (ETA and ETB) that are the cause of staphylococcal scalded skin syndrome (SSSS) occuring predominantly in children, and toxic shock syndrome toxin 1 (TSST-1) that causes staphylococcal toxic shock. ENTRY AND SPREAD WITHIN THE BODY S. aureus requires a breach in the skin or mucosa such as produced by a catheter, a surgical incision, a burn, a traumatic wound, ulceration or viral skin lesions to facilitate its entry into the tissues. Furthermore, staphylococcal infections are frequently associated with reduced host resistance brought about by cystic fibrosis, immunosuppression, diabetes mellitus, viral infections, and drug addiction. S. aureus has several enzymes that aid in invasion of the barrier epithelia and serve as spreading factors. Among these are lipases, hyaluronidase, and fibrinolysin. PERSON TO PERSON SPREAD Because they colonize the surface of the skin staphylococci are readily shed and easily transferred horizontally by direct contact or by contact with fomites such as bed linen, medical instruments, and so forth. Epidemiology: Transient colonization of the umbilical stump and skin, particularly in the perineal region, is common in neonates. About 15% of children and adults are persistent carriers of S. aureus in the anterior nares. There is a high rate of carriage in hospital personnel, IV drug users, diabetics, and dialysis patients, and MRSA and MSSA (methicillinsensitive S. aureus) colonization is common in the population. WHAT IS THE HOST RESPONSE TO THE INFECTION AND WHAT IS THE DISEASE PATHOGENESIS? PATHOGENESIS (INVASIVE AND TOXOGENIC) S. aureus is a versatile pathogen that causes a wide range of diseases. Disease may be mediated by invasion, bacterial multiplication leading to formation of abscesses, and destruction of a variety of tissues, as well as by a range of exotoxins, some of which are superantigens. Furthermore, S. aureus and other staphylococcal species are broadly antibiotic-resistant (see below). Factors contributing to the virulence of Staphylococcus aureus are presented in Table 1. SKIN INFECTIONS superficial such as impetigo infections of hair follicles (folliculitis) deeper infections like carbuncles boils (furuncles) S. aureus is a frequent cause of bacteremia and about half of these instances are nosocomial, associated with surgical wound infection and foreign bodies such as indwelling catheters, or sutures. From the blood S. aureus may seed many organs including the heart, lungs, bones, and joints. S. aureus endocarditis has a high mortality and may throw off septic emboli that may infect other organs. Pneumonia may result if bacteria reach the lungs via the bloodstream or as a result of aspiration. Acute and chronic osteomyelitis and septic arthritis may result from hematogenous spread or from a skin infection. TOXIGENIC DISEASE Enterotoxins (A–E, G–I) produced by S. aureus are the most common cause of food poisoning, with enterotoxin A causing most cases. Food poisoning results from the production of toxin in the foodstuff and its subsequent ingestion. The most frequently contaminated foods are salted meats, potato salad, custards, and ice cream. Generally, the food is contaminated by S. aureus on the hands of food preparers. Holding the food at room temperature allows the staphylococci to proliferate and produce toxin. The enterotoxins are heat-stable and tasteless so that, although heating of the food will kill the staphylococci, the enterotoxins are unaffected. The intoxication has a rapid onset, usually within 4 hours, and the symptoms are nausea, vomiting, diarrhea, and abdominal pain. Symptoms usually resolve within 24 hours. The mechanism(s) of action of the enterotoxins are not understood but may include mast cell activation and release of inflammatory mediators and neuropeptide substance P in the gastrointestinal tract and elsewhere. EXFLOLIATIN TOXIN Depended on immune state, produced by many strains of staph. Aurus belonging to phage group II. It cleaves stratum granulosum layer of epidermis. Ritter’s disease Lyell’s disease Scrlatina like rash Age Infant and young childreen Older childreen and adult Older childreen and adult Pathology Toxic epidermal necrolysis with large areas of denuded skin+generalized bullae (Scalded baby syndrom) Localized bulla red, moist, healing without scaring , if no 2ry bad.infection(Scalded skin syndrom) Resemle strept. Scarlet fever except no infection to tongue and palate TOXIC SHOCK SYNDROM(T.S.S) Caused by enterotoxin F produced by staph.aurus which is propaply indogenous flora of skin. Method of infection: Contamination of improper excessively, prolonged useof expandable(intravaginal tampon mad of synthetic materials) Contamination of wound Sing and symptoms: Haedach, nusea, vomiting, shock, death DIAGNOSIS 1. Sample from: pus folliculitis, frunculosis, corbancle sputum pneumonia blood bacteremia, endocarditis facese food poisoning 2 Examination: Direct film Culture: aerobic, ordinary media easly blood agar B-haemolysis Selective media Broth containing 7.5% NaCl Golden yellow staph. Aureus White staph. Epidermidis White-greyish white staph. saprophyticus BIOCHEMICAL REACTION A 7-year-old boy was well until yesterday when he developed dysphagia, painful anterior lymph nodes, and a fever to 40∞C. The patient vomited once and complained of a headache. Physical examination showed an acutely ill patient with a temperature of 39oC and a pulse of 104 beats per minute. Examination of his head, eyes, ear, nose, and throat revealed bilateral tonsillar hypertrophy with grayish-white exudates and punctate hemorrhages Bilateral tender submandibular lymph nodes were palpated. The remainder of the physical examination was within normal limits. A throat swab was obtained. Laboratory findings were: hemoglobin, normal; hematocrit, normal; WBC count, 19 000 mm3; differential, 80% PMN, 4% bands, 15% lymphocytes. 1. WHAT IS THE CAUSATIVE AGENT, HOW DOES IT ENTER THE BODY AND HOW DOES IT SPREAD (A). WITHIN THE BODY AND (B). FROM PERSON TO PERSON? ● S. pyogenes, also known as the group A streptococcus (GAS), is the most common cause of bacterial pharyngitis. ● The majority of cases (about 70%) of pharyngitis are caused by viruses. ● GAS is a gram-positive, catalase-negative coccus that grows in chains. ● GAS grows readily on blood agar incubated at 37C in the presence of 5% CO2 for 24–48 hours, forming small, gray opalescent colonies surrounded by a large zone of complete hemolysis (b-hemolysis). ● GAS has a typical gram-positive-type cell wall that features a thick peptidoglycan layer with covalently bound teichoic acid. ● M protein is the most important virulence factor of GAS and there are about 100 types. ● GAS has many determinants of pathogenesis that include lipoteichoic acid (pro-inflammatory), adhesins, superantigens (pyrogenic exotoxins), cytotoxins (streptolysin O and S), and a capsule. ● GAS is spread person to person via respiratory droplets, the hands, and fomites. ● GAS adheres to and invades epithelial cells from where it can invade subcutaneous tissues and seed the lymphatics and bloodstream. 2. WHAT IS THE HOST RESPONSE TO THE INFECTION AND ITS PATHOGENESIS? ● The barrier epithelia in concert with innate immune factors at these surfaces are effective barriers to the penetration of GAS. ● Host phagocytes are a second line of defense against GAS invasion. ● GAS is opsonized by activation of the alternate and lectin innate complement pathways and the classical pathway in the presence of anti-M protein antibodies in the plasma and tissue fluid. ● The virulence of GAS results from its ability to adhere to and invade host cells and to avoid opsonization and phagocytosis by means of capsule, M protein, and C5a peptidase. ● The hemolysins, streptolysin S and O, are cytotoxins that can lyse erythrocytes, leukocytes, and platelets and likely other host cells. ● The pyrogenic exotoxins (erythrogenic toxins) are superantigens that result in the release of proinflammatory cytokines that mediate shock and organ failure characteristic of streptococcal toxic shock syndrome and give rise to the rash associated with scarlet fever. 3. WHAT IS THE TYPICAL CLINICAL PRESENTATION AND WHAT COMPLICATIONS CAN OCCUR? ● Pharyngitis occurs 24–48 hours post-exposure with sudden onset of sore throat, malaise, fever, headache, and erythematous pharynx and tonsils with creamy, yellow exudates and cervical lymphadenopathy. ● Scarlet fever is caused by GAS strains lysogenized by a temperate bacteriophage that specifies production of pyrogenic exotoxin resulting in an erythematous rash, circumoral pallor, and strawberry tongue. ● Pyoderma (impetigo) is a highly contagious, superficial infection of exposed skin, typically the face, arms, and legs, characterized by vesicles that progress to pustules that rupture and are replaced by honey-colored crusts. ● Erysipelas is an acute infection of the skin, most frequently the legs, accompanied by lymphadenopathy, fever, chills, and leukocytosis in which the infected skin is painful, inflamed, raised, and clearly demarcated. Cellulitis is an infection similar in nature to erysipelas except that it involves not only the skin but the connective tissues. ● Necrotizing fasciitis is a deep infection of the connective tissue that spreads along fascial planes and destroys muscle and fat. ● Streptococcal toxic shock syndrome (STSS) often follows necrotizing fasciitis; the disease is characterized by shock and organ failure. ● Acute rheumatic fever (ARF) is an autoimmune inflammatory disease of the connective tissue, particularly the heart, joints, blood vessels, subcutaneous tissue, and central nervous system that occurs about 3 weeks after GAS pharyngitis in susceptible subjects. ● Acute glomerulonephritis (AGN) is an autoimmune disease that can follow either pharyngeal or skin infection causing inflammation of the glomeruli, hypertension, hematuria, and proteinuria. edema, 4.HOW IS THE DISEASE DIAGNOSED AND WHAT IS THE DIFFERENTIAL DIAGNOSIS? ● Microscopy: Examination of infected tissues or body fluids stained by Gram’s method can provide a rapid preliminary diagnosis. ● Culture: Swabs from the posterior pharynx, undisturbed crusted pustules, tissue, pus, blood, and so forth, are plated onto blood agar to grow the characteristic colonies surrounded by a large zone of b-hemolysis. ● Determinative tests: Susceptible to bacitracin and PYRpositive. ● Antigen detection: Rapid tests based on immunological detection of the Lancefield group A wall carbohydrate antigen are available to directly detect GAS on throat swabs; a negative rapid test must be confirmed by culture. ● Serology: Anti-streptolysin O titer (the ASO titer) is a useful marker for confirming acute rheumatic fever or acute glomerulonephritis resulting from GAS pharyngitis; anti-DNase B for AGN following skin infection. 5. HOW IS THE DISEASE MANAGED AND PREVENTED? ● Penicillin is the antibiotic of choice in patients who are not hypersensitive. ● Erythromycin or a cephalosporin can be used in patients allergic to penicillin. ● Antibiotic treatment of GAS pharyngitis prevents the development of rheumatic fever. ● Serious soft tissue infections require drainage and surgical debridement as the first line of therapy. ● Prophylactic antibiotic therapy is required for several years in individuals who have had rheumatic fever. ● Any person with pre-existing damage to their heart valves should receive prophylactic antibiotics before any procedure likely to result in transient bacteremia, such as dental treatment. PATHOGENICITY 1. Rheumatic Fever A. Rheumatic toxins (streoptolysin O) B. Autoimmunity C. Cross reactivity D. Genetic and anatomic aberration 2. Acute glumerulonephritis 3. Migratory arthiritis Scarlet fever Puerperal sepsis Acute follicular tonsilitis Erysipelas BACTERIAL DIAGNOSIS I. II. A. History: Clinical examination Laboratory Diagnosis: Direct: source pus, sputum, urine, blood, urine, stool,………. suitable time preparation( signs of growth) 1. Direct film stain Gram Ziehl-Neelsen stain 2. Culture: a. Cultural character: O2, Co2, O.T , pH b. Media Ordinary Enriched selective Differentiated c. Morphological characters of colonies: haemolysis, shape,………. Systemic examination of isolated colonies pigment, 1.Microscopy stained by : special stain (spor, capsule) other technigues(motility) 2. Biochemical reaction and antibiotic senstivity test 3. Animal inoculation: Susceptable animal procedure, route of injection effect and P.M picture Ex. Pneumococci (mice) Diphtheria (G.P and rabite) Cl. Teteni (G.p , mice, rabbite) T.B. (G.P, rabbite 4. slide aglutination test by using specific antisera Other methodsof typing (Staph., strept.) B. Indirect: Serology test: pationt serum detected for Ad Interadermal tests for T.B, Brucella, Leprosy Staining methods: 1. Making of a film 2. Staining of film by: a. Simple stain: (Methylen blue or Diluted carbol fuchsin) . b. Differential stain c. Special stain All cocci are gram positive except Neisseria group All Bacilli are gram negative except • Corynebacterium group • Anthrax and Anthracoids • Clostridium group • Lactobacillus group ZIEHL-NEELSEN STAIN Concentrated carbol fuchsin Sulphoric acid 20% Alcohol 95% Methylene blue